Skip to main content

Medications for Functional Constipation

Functional constipation (FC) is a chronic condition characterized by hard, infrequent bowel movements that are often painful or difficult to pass.

Constipation is defined as functional constipation if there is no underlying organic cause. 

Functional constipation is a common problem in childhood, and often occurs in preschool children around the time of toilet training.

Events or triggers that can lead to functional constipation in toddlers include painful or frightening defecation, dietary changes after breastfeeding, and stress and anxiety during toilet training. In older children, triggers for FC include avoidance of unpleasant toilet facilities away from home, voluntary withholding while playing, and trauma to the perianal area.

After initial disimpaction (emptying the hard stool from the colon), maintenance treatments for functional constipation include osmotic laxatives (polyethylene glycol 3350, lactulose, magnesium hydroxide), stool softeners (docusate sodium), and stimulant laxatives (senna, bisacodyl).

Linzess (linaclotide) is an FDA-approved prescription therapy indicated for functional constipation in pediatric patients ages 6-17 years.

 

 

 

 

Drugs used to treat Functional Constipation

The medications listed below are related to or used in the treatment of this condition.

Drug name Rating Reviews Activity ? Rx/OTC Pregnancy CSA Alcohol
Linzess 9.0 1 review for Linzess to treat Functional Constipation Rx C N
Generic name:
linaclotide systemic
Drug class:
guanylate cyclase-C agonists
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
linaclotide 9.0 1 review for linaclotide to treat Functional Constipation Rx C N
Generic name:
linaclotide systemic
Brand name:
Linzess
Drug class:
guanylate cyclase-C agonists
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph

Frequently asked questions

Learn more about Functional Constipation

Care guides

Legend

Rating For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective).
Activity Activity is based on recent site visitor activity relative to other medications in the list.
Rx Prescription only.
OTC Over-the-counter.
Rx/OTC Prescription or Over-the-counter.
Off-label This medication may not be approved by the FDA for the treatment of this condition.
EUA An Emergency Use Authorization (EUA) allows the FDA to authorize unapproved medical products or unapproved uses of approved medical products to be used in a declared public health emergency when there are no adequate, approved, and available alternatives.
Expanded Access Expanded Access is a potential pathway for a patient with a serious or immediately life-threatening disease or condition to gain access to an investigational medical product (drug, biologic, or medical device) for treatment outside of clinical trials when no comparable or satisfactory alternative therapy options are available.
Pregnancy Category
A Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters).
B Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
C Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
D There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
X Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use in pregnant women clearly outweigh potential benefits.
N FDA has not classified the drug.
Controlled Substances Act (CSA) Schedule
M The drug has multiple schedules. The schedule may depend on the exact dosage form or strength of the medication.
U CSA Schedule is unknown.
N Is not subject to the Controlled Substances Act.
1 Has a high potential for abuse. Has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use under medical supervision.
2 Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence.
3 Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence.
4 Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3.
5 Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4.
Alcohol
X Interacts with Alcohol.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.